Visceral hypersensitivity is a heightened pain response from the internal organs, most commonly the gut, where stimuli that should feel mild or go unnoticed instead register as painful. It is considered a hallmark feature of irritable bowel syndrome (IBS) and several related conditions. The phenomenon involves both an overly reactive nerve supply in the gut wall and amplified processing of those signals in the spinal cord and brain, which means the problem is not “all in your head” and not purely in your gut either. Understanding what drives it has reshaped how researchers and clinicians think about chronic abdominal pain and opened up treatment approaches that go well beyond older assumptions.
What Actually Happens Inside the Gut’s Nervous System
Your gut has its own extensive nerve network, sometimes called the “second brain,” that constantly sends signals to your spinal cord and brain about what is going on inside. In a person with visceral hypersensitivity, this signaling goes wrong in two key ways. The first is hyperalgesia, where something that would normally cause mild discomfort, like gas stretching the bowel wall, produces intense pain. The second is allodynia, where a completely normal sensation, like food moving through the intestines, triggers pain when it should not be felt at all.1Journal of Neurogastroenterology and Motility. The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments Together, these mean that the volume knob on gut sensation is turned up too high.
The sensitization can happen at multiple levels. At the peripheral level, nerve endings in the gut wall become more excitable. This can involve changes to ion channels on sensory neurons, meaning the threshold for firing off a pain signal drops. At the central level, neurons in the spinal cord that relay gut signals to the brain become hyperexcitable too, amplifying signals that were already too loud. And at the brain level, areas involved in processing pain and emotional context can respond more strongly than they should.2PubMed. Peripheral and central mechanisms of visceral sensitization in man People with IBS show heightened sensitivity not just to gut stimuli but sometimes to pain elsewhere in the body, which points to the central nervous system playing a real role in the problem.3PubMed Central. Molecular Mechanisms and Pathways in Visceral Pain
The Immune System’s Involvement
One of the more important discoveries in recent years is that gut immune cells, particularly mast cells, appear to be a major driver of the pain signaling that underlies visceral hypersensitivity. Mast cells sit close to nerve endings in the gut wall, and when they become overactive, they release chemicals that directly stimulate those nerves. This altered communication between immune cells and pain-sensing nerves has been identified as a hallmark driver of IBS-related abdominal pain.4Cell Press. Mast cell modulation: A novel therapeutic strategy for abdominal pain in irritable bowel syndrome It also helps explain why some people develop visceral hypersensitivity after a gut infection or a flare of inflammatory bowel disease: the immune activation subsides, but the nerve sensitization it triggered persists.
Research into gut barrier function adds another layer. When the lining of the intestine becomes more permeable, sometimes called “leaky gut” in popular terms, bacterial products can seep through and provoke low-grade immune activation near nerve endings. The estimated prevalence of barrier dysfunction in IBS varies widely across studies, and it tends to be more common in people with diarrhea-predominant IBS or post-infectious IBS.5PubMed Central. Multi-omics for biomarker approaches in the diagnostic evaluation and management of abdominal pain and irritable bowel syndrome: what lies ahead This is not a simple “leaky gut causes all problems” story, but it does appear to be one piece of a larger puzzle in certain subgroups of patients.
Stress and the Gut-Brain Axis
Stress is one of the most consistently documented factors that worsens visceral hypersensitivity. Long-term stress sensitizes pain pathways and promotes conditions like IBS through activation of the body’s stress-response system.6PubMed Central. Mechanisms of Stress-induced Visceral Pain Chronic stress can change how pain circuits in the brain are wired, alter how fast or slowly the gut moves, and increase the permeability of the intestinal lining.7PubMed Central. Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome
Early life stress appears to be particularly impactful. Adverse experiences during childhood can shape how the stress-response system develops, and evidence suggests this can set someone up for heightened visceral pain sensitivity later in life.6PubMed Central. Mechanisms of Stress-induced Visceral Pain More recent research has begun to uncover how this works at a molecular level: chronic stress can alter gene expression through what are called epigenetic changes, which in turn can reduce the integrity of the gut barrier and shift the composition of gut bacteria, both of which feed back into increased pain sensitivity.8PubMed Central. The Role of Epigenomic Regulatory Pathways in the Gut-Brain Axis and Visceral Hyperalgesia
This does not mean the condition is psychological. The relationship between stress and visceral hypersensitivity is bidirectional and biological. Gut distress itself generates stress signals to the brain, and those brain-level changes then amplify gut signals. The modern framing used by researchers refers to conditions like IBS as disorders of “gut-brain interaction” rather than the older “functional” or “psychogenic” labels, emphasizing that the gut’s biology matters at least as much as the brain’s.9PubMed. Marshall and Warren Lecture 2019: A paradigm shift in pathophysiological basis of irritable bowel syndrome and its implication on treatment
When Infections Leave Lasting Pain
A significant number of people develop IBS symptoms for the first time after a bout of food poisoning or gastroenteritis. This is known as post-infectious IBS, and visceral hypersensitivity is a central feature of it.10PubMed Central. Post-infectious irritable bowel syndrome What makes post-infectious IBS striking is that the original infection resolves completely, yet the pain and altered bowel habits persist for months or years afterward.
Research has shown that the nerve signaling within the bowel wall of post-infectious IBS patients remains sensitized at least two years after the initial infection has cleared. This sensitization appears to be driven by a lasting change in the gut’s chemical environment that continues to stimulate pain-sensing nerve fibers.11Scientific Reports. Evidence for long-term sensitization of the bowel in patients with post-infectious-IBS Common enteric pathogens can trigger these chronic changes through various mechanisms, including residual low-grade inflammation, shifts in the gut microbiome, and direct effects on nerve function.12PubMed Central. Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection If you have ever wondered why your gut “never felt the same” after a bad stomach bug, this is a plausible biological explanation.
Symptoms Beyond Just Abdominal Pain
The most prominent symptom of visceral hypersensitivity is abdominal pain, but the experience varies considerably. Pain can be crampy, burning, sharp, or a dull ache. It is often linked to meals, bowel movements, or emotional stress. Bloating is extremely common and frequently reported as one of the most bothersome symptoms, sometimes even more than pain itself. Many people describe a feeling of fullness or pressure that seems disproportionate to what they have eaten.
Visceral hypersensitivity can also manifest outside the lower gut. Some people experience heightened sensitivity in the upper digestive tract, contributing to conditions like non-ulcer dyspepsia (chronic indigestion without an identifiable cause) or non-cardiac chest pain, where the esophagus overreacts to normal stimuli like acid reflux.13Gastroenterology. Basic and clinical aspects of visceral hyperalgesia The pain in these cases can develop through some of the same peripheral and central mechanisms that drive lower-gut hypersensitivity.
A hallmark of the condition is that standard tests come back normal. Endoscopy, imaging, and blood work typically reveal no structural abnormality. This used to lead to dismissal, but the current understanding is that the nervous system itself is the site of the problem, and standard diagnostic imaging is not designed to detect neural sensitization.
How Visceral Hypersensitivity Is Measured
The most established research tool for measuring visceral hypersensitivity is the rectal barostat, a device that inflates a small balloon inside the rectum at controlled pressures and records when the person first feels a sensation, urgency, and pain. At a distension pressure of 40 mmHg, this test showed high accuracy in distinguishing IBS patients from healthy controls and non-IBS patients, with sensitivity above 95% and specificity around 72%.14Gastroenterology. Rectal distention testing in patients with irritable bowel syndrome: Sensitivity, specificity, and predictive values of pain sensory thresholds
There is a catch, though. The way the barostat test is performed matters a great deal. Different inflation protocols produce very different results: in one study, one protocol classified about half of IBS patients as hypersensitive, while a different protocol in the same population classified only about 10%.15Journal of Neurogastroenterology and Motility. Type of Rectal Barostat Protocol Affects Classification of Hypersensitivity and Prediction of Symptom Severity in Irritable Bowel Syndrome This inconsistency is one reason the barostat has remained primarily a research tool rather than a routine clinical test. In practice, most doctors diagnose visceral hypersensitivity based on symptom patterns and the absence of structural disease, rather than with specialized equipment.
Researchers are actively working on non-invasive biomarkers that could eventually replace or supplement the barostat. Candidates include measures of gut permeability, inflammatory markers, and even multi-omic profiling that combines gut bacteria analysis with metabolic and immune markers. But identifying and validating biomarkers of visceral hypersensitivity remains particularly challenging, and none have reached routine clinical use yet.5PubMed Central. Multi-omics for biomarker approaches in the diagnostic evaluation and management of abdominal pain and irritable bowel syndrome: what lies ahead
Medications That Work in the Gut
Several medications target visceral hypersensitivity from the gut side. Linaclotide, a drug approved for IBS with constipation, works by activating receptors on the gut lining that increase fluid secretion into the intestine. But beyond its laxative effect, linaclotide has a separate pain-reducing action: it inhibits colonic pain-sensing nerves, and this effect is actually stronger when chronic visceral hypersensitivity is present. In animal studies, giving linaclotide directly into the colon reduced the pain signals reaching the spinal cord.16PubMed. Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3′,5′-monophosphate Longer-term treatment in mice has been shown to reverse not only the local nerve hypersensitivity but also some of the changes in spinal cord circuitry that had developed as a result of chronic gut inflammation.17The Journal of Clinical Investigation. Chronic linaclotide treatment reduces colitis-induced neuroplasticity and reverses persistent bladder dysfunction
Antispasmodics are another common choice. Some, like otilonium bromide, work by blocking calcium channels on smooth muscle and nerve cells in the gut. In a randomized trial of 355 IBS patients, otilonium bromide reduced abdominal pain frequency compared to placebo.5PubMed Central. Multi-omics for biomarker approaches in the diagnostic evaluation and management of abdominal pain and irritable bowel syndrome: what lies ahead Pregabalin, a medication more commonly associated with nerve pain and anxiety, has also shown benefit in IBS by increasing pain thresholds, particularly in the diarrhea-predominant subtype.
Neuromodulators and Central Approaches
Because visceral hypersensitivity has a strong central nervous system component, medications that act on the brain’s pain processing can be effective even though the pain originates in the gut. Tricyclic antidepressants, especially at low doses, are among the most commonly used. Amitriptyline, for example, has been shown to reduce pain-related brain activation in IBS patients, specifically in regions involved in emotional and stress-related processing of pain. The effect was most pronounced during stress, suggesting the drug helps by dampening the brain’s tendency to amplify gut signals when under pressure.18PubMed. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome
The doses used for visceral pain are typically much lower than those prescribed for depression. This is worth knowing because many patients understandably resist being prescribed an “antidepressant” for a gut problem, feeling it implies their symptoms are not real. In this context, these drugs are being used for their effects on nerve signaling, not for their mood-altering properties. The name is misleading, and clinicians increasingly use the term “neuromodulators” instead to reduce this confusion.
Psychological Therapies That Change Gut Sensation
Cognitive behavioral therapy (CBT) and gut-directed hypnotherapy are the two best-studied psychological approaches for visceral hypersensitivity. Both have shown consistent benefit for IBS symptoms, including pain severity, quality of life, and associated anxiety and depression. A systematic review of psychological therapies for refractory IBS, meaning cases that had not responded to standard medical treatment, found that CBT consistently improved symptom severity and frequency. Gut-directed hypnotherapy and biofeedback therapy also produced significant improvements across all measured domains, with no clear difference between the two.19PubMed Central. The Use of Psychotherapy for Refractory Irritable Bowel Syndrome: A Systematic Review
Gut-directed hypnotherapy works differently from stage hypnosis. It involves guided relaxation and suggestion focused specifically on normalizing gut sensation and function. Sessions are typically delivered over several weeks, and benefits have been shown to last well beyond the treatment period. The fact that these therapies work for refractory cases, where medications had failed, underscores that the brain’s processing of gut signals is a legitimate therapeutic target, not a consolation prize when “real” treatments fall short.
Dietary Strategies
The low-FODMAP diet has become the most widely recommended dietary approach for IBS, and there is growing evidence that it specifically affects visceral hypersensitivity rather than just altering stool consistency. In animal models of stress-induced visceral hypersensitivity, a low-FODMAP diet raised the pain threshold and improved colonic blood flow.20PubMed Central. Low FODMAP Diet Relieves Visceral Hypersensitivity and Is Associated with Changes in Colonic Microcirculation in Water Avoidance Mice Model Separate research found that the diet normalized pain responses to colon distension, reduced inflammatory signaling, and prevented the increase in gut permeability and circulating bacterial toxins that stress had provoked.21JCI Insight. FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction
These findings suggest the low-FODMAP diet does more than just reduce gas and bloating by removing fermentable sugars. It appears to calm the gut’s immune and barrier environment in ways that reduce the signals feeding into hypersensitivity. The diet is not meant to be permanent; it involves an elimination phase followed by systematic reintroduction to identify individual triggers. Working with a dietitian familiar with the protocol makes a meaningful difference in both adherence and outcomes.
Sex Differences and Hormonal Influences
Women are roughly twice as likely as men to be diagnosed with IBS, and research into visceral hypersensitivity is beginning to explain part of why. In animal models of post-inflammatory gut pain, females with normal hormone cycles showed significantly greater visceral hypersensitivity compared to males. Removing estrogen through ovariectomy reduced that heightened sensitivity, bringing it closer to male levels.22Journal of the Canadian Association of Gastroenterology. A52 SEX DIFFERENCES IN POST-INFLAMMATORY VISCERAL PAIN IN A MOUSE MODEL OF INFLAMMATORY BOWEL DISEASE (IBD) This points to estrogen as an important biological factor in how severely the gut’s pain system responds after inflammation.
Many women with IBS report that their symptoms fluctuate with their menstrual cycle, often worsening in the days around menstruation when estrogen and progesterone levels shift. While the exact mechanisms are still being studied, the emerging picture is that female sex hormones modulate both the gut’s sensitivity to distension and the central processing of those signals. This has practical implications: treatment plans may need to account for cyclical symptom variation, and hormonal treatments could eventually become part of the management toolkit for some patients.
Overlap with Other Chronic Pain Conditions
Visceral hypersensitivity rarely exists in isolation. IBS commonly coexists with other chronic pain conditions, including fibromyalgia, temporomandibular joint disorder, painful bladder syndrome, and chronic fatigue syndrome.23PubMed Central. Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? This pattern of overlap suggests that in many people, the underlying problem may be a broader sensitization of the nervous system rather than something specific to the gut alone.
Children and adolescents with inflammatory bowel disease like Crohn’s disease also show evidence of visceral hypersensitivity. In one study, young Crohn’s patients had rectal sensitivity thresholds roughly 40% lower than healthy controls, and their thresholds were similar to those of children diagnosed with functional gastrointestinal disorders. Most of those patients also showed signs of significant anxiety.24PubMed. Functional gastrointestinal disorders and visceral hypersensitivity in children and adolescents suffering from Crohn’s disease This finding is clinically meaningful: in a child with Crohn’s who reports ongoing pain despite well-controlled inflammation, visceral hypersensitivity rather than active disease may be the culprit, and the treatment approach needs to reflect that.
The Microbiome as a Potential Therapeutic Target
The composition of gut bacteria appears to influence visceral sensitivity, and researchers have begun testing whether changing the microbiome can change the pain. In a post-infectious mouse model, fecal microbiota transplantation raised pain thresholds and was as effective as supplementation with Bifidobacterium in relieving visceral hypersensitivity.25PubMed Central. Fecal Microbiota Transplantation Is Effective in Relieving Visceral Hypersensitivity in a Postinfectious Model Another study using fecal microbiota transplantation confirmed that gut bacteria actively modulate visceral sensitivity, though the exact mechanism did not appear to involve changes to colon structure or permeability.26PubMed Central. Visceral sensitivity modulation by faecal microbiota transplantation: the active role of gut bacteria in pain persistence
These results are still in the animal and early clinical stage, and fecal transplantation for IBS is not standard practice. But the findings point in an interesting direction: the bacteria living in your gut are not just bystanders in visceral pain. They produce metabolites that can either calm or excite nerve endings, influence immune cell behavior near those nerves, and affect the integrity of the gut barrier. As the tools for analyzing and manipulating the microbiome become more refined, targeted microbial therapies could eventually join the treatment landscape for visceral hypersensitivity in a more precise way than the current broad-spectrum probiotics that most people try first.